- Investing Ideas
- /
- Australian Pharmaceuticals & Biotech Mid-Large Cap Stocks
Australian Pharmaceuticals & Biotech Mid-Large Cap Stocks
Results
4
Mid-Large Cap Stocks
4 companies
CSL
Market Cap: AU$94.0b
Engages in the research, development, manufacture, market, and distribution of biopharmaceutical products and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally.
CSL
AU$194.23
7D
-2.1%
1Y
-31.9%
Neuren Pharmaceuticals
Market Cap: AU$2.4b
A biopharmaceutical company, develops drugs for the treatment of neurological disorders.
NEU
AU$19.39
7D
-2.2%
1Y
27.0%
Mesoblast
Market Cap: AU$3.1b
Engages in the development of regenerative medicine products in Australia, the United States, Singapore, and Switzerland.
MSB
AU$2.40
7D
-0.4%
1Y
113.3%
Telix Pharmaceuticals
Market Cap: AU$5.0b
A commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals.
TLX
AU$14.85
7D
2.2%
1Y
-27.3%